Related Experiment Video
Updated: Jul 2, 2025
Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
Therapeutic index of targeting select chromatin complexes in human cancer patients
Yuan Gao1, Christopher R Vakoc1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Abstract:
Aberrant chromatin regulation can promote the initiation and progression of human cancer. An improved understanding of such mechanisms has resulted in the identification of cancers with an enhanced dependency on specific chromatin regulatory proteins relative to nonmalignant cell types. Hence, targeting of such complexes with small molecules has significant therapeutic potential in oncology. In recent years, several drugs have been developed and evaluated in human cancer patients, which can influence tumor biology by reprogramming of chromatin structure. In this review, we summarize several of the known mechanisms that endow cancer cells with a powerful dependency on chromatin regulation that exceeds the requirements for normal tissue homeostasis. We also summarize the remarkable small-molecule inhibitors that exploit chromatin regulator dependencies with a clear therapeutic benefit in human cancer patients.
Insights
Cancer cells rely heavily on aberrant chromatin regulation for growth. Small-molecule inhibitors targeting these specific chromatin dependencies offer promising therapeutic strategies for oncology, with several already showing clinical benefits.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Aberrant chromatin regulation is a key driver in human cancer initiation and progression.
- Cancer cells exhibit unique dependencies on specific chromatin regulatory proteins compared to normal cells.
- Understanding these dependencies is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To review mechanisms underlying cancer cell dependency on chromatin regulation.
- To summarize small-molecule inhibitors targeting these dependencies.
- To highlight the therapeutic potential of targeting chromatin regulation in oncology.
Main Methods:
- Literature review of studies on chromatin regulation in cancer.
- Analysis of mechanisms conferring cancer cell dependency on chromatin regulators.
- Summary of clinical data for small-molecule inhibitors targeting chromatin pathways.
Main Results:
- Cancer cells exhibit heightened dependence on chromatin regulation for survival and proliferation.
- Several classes of small-molecule inhibitors targeting chromatin regulators have been developed.
- These inhibitors demonstrate therapeutic benefits in human cancer patients by reprogramming chromatin structure.
Conclusions:
- Targeting cancer-specific chromatin dependencies represents a viable therapeutic strategy.
- Small-molecule inhibitors offer a promising approach to exploit these vulnerabilities in cancer treatment.
- Further research into chromatin regulation mechanisms can lead to novel oncology drugs.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:36Chromatin Immunoprecipitation- ChIP
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...